Clinical significance of assertive community treatment among adolescents. by Mantzouranis, G. et al.
   
 
 
 
 
Serveur Acade´mique Lausannois SERVAL serval.unil.ch
Author Manuscript
Faculty of Biology and Medicine Publication
This paper has been peer-reviewed but does not include the final publisher
proof-corrections or journal pagination.
Published in final edited form as:
Title: Clinical significance of assertive community treatment among
adolescents.
Authors: Mantzouranis G, Baier V, Holzer L, Urben S, Villard E
Journal: Social psychiatry and psychiatric epidemiology
Year: 2018 Oct 11
DOI: 10.1007/s00127-018-1613-z
In the absence of a copyright statement, users should assume that standard copyright protection applies, unless the article contains
an explicit statement to the contrary. In case of doubt, contact the journal publisher to verify the copyright status of an article.
ACT EFFICACY IN ADOLESCENTS  1 
 
 
 
Abstract 
Purpose: The efficacy of assertive community treatment for children and adolescents is proven in the 
United States, but remains controversial in Europe. Moreover, most studies showing positive outcomes of 
assertive community treatment are limited to statistically significant differences and don’t consider 
whether the treatment is also subjectively clinically meaningful for the patient. Using a naturalistic 
sample, the present study aims to assess statistical and clinical significance of an assertive community 
treatment unit for adolescents in Europe. Methods: Linear mixed-effects models and reliable change 
indices were used to respectively assess statistical and clinical significance of assertive community 
treatment in 179 adolescents (mean age = 15.76, SD = 1.76) with severe mental illnesses. Results: 
Difficulties related to mental health (measured by the Health of the Nation Outcome Scales for Children 
and Adolescents, HoNOSCA) and overall functioning (measured by the Global Assessment of 
Functioning scale) statistically improved (all ps < .001) from admission to discharge. Additionally, a 
considerable proportion of patients (from 14% to 21%) clinically recovered to functional levels. 
Conclusion: Our results support the fact that assertive community treatment can have convincing and 
positive clinical outcomes in European settings. 
 Keywords: assertive community treatment, treatment efficacy, adolescents, HoNOSCA, reliable 
change index. 
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Effectiveness of Assertive Community Treatment Regarding Reliable Change among Adolescents  
 Assertive community treatment (ACT) for children and adolescents with serious mental illness is 
an important part of the mental health system. It constitutes a middle term between hospitalization and 
occasional outpatient treatment, and thus complements both types of treatment whenever emergency 
hospitalization would be too heavy or when standard outpatient treatment would be too light [1]. ACT is 
also particularly used to provide care to severely ill patients who tend to refuse care or traditional 
outpatient treatment. Assertive outreach allows ACT to avoid drop-outs from treatment and breaks of 
contact with the healthcare system. Among adult patients, ACT has proved to be efficient, on the one 
hand, in reducing psychiatric symptoms and length of inpatient stay, and on the other hand, in improving 
social functioning, adherence to medication and employability [2,3]. 
 However, a recent systematic review showed that there are comparatively few studies having 
examined the efficacy of ACT on adolescent populations [4]. Most of them led to consistent results and 
showed statistically significant improvements after ACT on social and symptomatic fields. One other 
study highlighted that a newly implemented ACT program designed to care for youth transitioning from 
adolescence to adulthood led to significant improvements in both objective and subjective outcomes, such 
as, respectively, limitation of penal consequences or improvement in overall functioning [5]. A 
randomized controlled trial on drug- and alcohol-dependent adolescents also showed a significant 
reduction in symptoms for the patients assigned to ACT [6]. Similar conclusions were reached in a study 
on adolescents at high psychiatric risk who were followed by ACT teams, where post-treatment 
assessments showed a significant decrease in aggressive and self-harming behaviors [7]. Finally, a Swiss 
study compared assessments before and after ACT treatment on adolescents with a wide range of severe 
psychiatric disorders and showed a significant decrease of their social and symptomatic difficulties [1]. 
Even though all these results seem rather promising, the improvements after ACT are significant only in 
the statistical sense. Indeed, the statistical tests only point out whether the observed differences after 
treatment are due to chance alone, but don’t imply that the differences are large enough to be noticed by 
the patient. In other words, a statistical difference between pre- and post-treatment assessments doesn’t 
necessary mean that this difference is clinically meaningful for the patient. 
 Clinical significance differs from statistical significance in the sense that the former is based on 
expectations set by patients, clinicians, and researchers [8], whereas the latter only refers to the 
probability of rejecting a null hypothesis and doesn’t implies that this evidence is meaningful. Typical 
expectations regarding a given type of treatment may be that by its end patients regain normative levels of 
functioning or that their problems are solved. In order to determine clinical significance, several methods 
have been proposed [8-10]. One of the most frequently used is the reliable change index [RCI; 11]. This 
index allows the comparison of pre- and post-treatment scores by taking into account the expected scores 
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of a normal population and the measurement error of the instruments used. Originally, two conditions 
were necessary to consider a treatment as being unequivocally effective [11]: (a) the amount of change in 
outcome measures was to be significantly reliable, that is, the RCI was to be greater than or equal to 1.96 
and (b) patients’ scores were to pass from dysfunctional to normative values after treatment. However, the 
use of both criteria has recently been considered as very conservative and unrealistic for many clinical 
contexts [12]. The most recommended approach used in recent research is to only consider the first 
criterion and to moderate its interpretation, that is, to consider values of the RCI greater or equal to 1.96 
as a clinically significant improvement rather than as complete recovery. Conversely, when the RCI is 
smaller than or equal to -1.96, then the patient is considered as having deteriorated during treatment. 
Because the RCI is widely used in different areas of psychology [13,14], and because its performances are 
similar to other indices, it has been recommended in studies on treatment efficacy [15]. Indeed, the use of 
a single method that has proved to perform well allows for easier comparisons between studies. Despite 
this, there is currently no study using the RCI to assess the efficacy of ACT on adolescent populations.  
 
The current study 
 The general objective of our study is to investigate the efficacy of ACT in a natural setting. The 
first objective of our study is to assess whether ACT has a statistically significant impact on patients’ 
symptoms and social functioning. We thus expect patients to present less symptoms and an improved 
social functioning after treatment. Our second objective is then to extend these results by testing whether 
the impact of ACT exceeds statistical significance and reaches clinical significance. Therefore, we will 
focus on the RCI of each treatment outcome to investigate whether ACT has clear clinical benefits. 
 
Methods 
Participants 
 All the adolescents followed by the ACT teams in the Vaud canton in Switzerland between 2010 
and 2014 were included in the study; none of them were excluded for any reason, so that the sample most 
closely resembles the usual patients that the teams meet in “real world” situations. This way, the study 
remains as naturalistic as possible. Descriptive statistics of our sample are provided in Table 1. In total, 
179 participants took part in this study (mean age = 15.76 years, SD = 1.76 year), 77 girls (43.02%) and 
102 boys (56.98%). Most of them lived with at least one of their parents (104/179, 58.10%), 56 (31.28%) 
were placed in foster care or in a social care institution, and 5 (2.79%) lived alone or didn’t have a home 
address. Approximately one third of the participants were school drop outs when the ACT was 
introduced. Among our respondents, 38.26% received social measures, such as help in schooling, 
curatorship, withdrawal of child custody or of parental authority, or any other type of social help. Eighty-
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five participants suffered from a previous traumatic experience (such as migration, adoption, physical 
abuse, parent separation), with most of them (75/85, 88.24%) having had more than one type. Almost half 
of our participants (89/179, 49.72%) used legal or illegal psychoactive substances, among which 39 
(43.82%) used more than one. Due to the naturalistic setting of the study, a set duration of treatment was 
not fixed in advance. Thus, the mean duration of the treatment was 185.46 days, with a large variation 
depending on the patients (SD = 136.85). Among the participants with a known history of psychiatric 
care, about 20 suffered from psychiatric symptoms for less than one year (11.7%), 42 of them for one to 
five years (23.46%), and 35 for more than five years (19.55%). Twenty-two patients did not have a 
psychiatric diagnosis because they have been addressed to the ACT teams by non-medical structures (e.g., 
schools, youth protection services) and because a psychiatrist of the ACT team has not been involved. 
Patients were assessed at the beginning of the ACT and at discharge by a member of the ACT team. There 
were no dropouts, but thirty-one participants didn’t have complete data at discharge, because they didn’t 
want to meet ACT teams again after discharge, end of care was decided by phone, or end of care was not 
clearly formalized.  
 
Intervention 
 ACT is provided by a multidisciplinary team (composed of psychiatrists, nurses, and social 
workers) working together and sharing responsibility for each patient [for a detailed description, see 16]. 
According to the ACT model, the interventions are flexible and follow a “no drop-out” policy, meaning 
that reluctant patients are still contacted and offered services. The interventions are provided in the usual 
social environment of the patients (at home, at school, in cafés), with a high frequency of meetings (up to 
10 times a week), and involve their families directly in the treatment. Five main types of interventions are 
provided by the teams: (1) early intervention aims at reducing the duration of untreated disorder and at 
avoiding its aggravation by promoting a child and adolescent psychiatric monitoring, by setting up 
medications, and by sustaining professional or school integration (nine patients; 5%); (2) transition case 
management is provided near the end of an hospitalization and lasts during a couple of weeks after 
leaving the hospital in order to make the transition to the return home easier and to avoid a relapse (37 
patients; 20.7%); (3) care provided to hardly accessible patients or in refusal of care proceeds from the 
no drop-out policy of the model and aims at (re)establishing a therapeutic alliance between adolescents at 
high psychopathological risk and the health care professionals involved in the situation (81 patients; 
45.3%); (4) psychiatric assessment in the community consists in assessing the care the patients need in the 
very structures that host them (e.g., schools, juvenile prisons, social care institutions) and in supporting 
the expertise of the care network (41 patients; 22.9%); (5) support in socio-educational institutions is 
provided to overcome the absence of psychiatric homes for adolescents in Switzerland and permits a 
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therapeutic follow-up for the patient as well as supervisions/intervisions for the socio-educational staff 
(11 patients; 6.1%). 
 
Instruments  
 
  Difficulties related to mental illness. The French version of the Health of the Nation Outcome 
Scales for Children and Adolescents [HoNOSCA, 17,18] is a short, reliable, and sensitive instrument used 
internationally to assess a broad spectrum of difficulties associated with mental illness [19-21]. More 
specifically, the HoNOSCA items require the clinician to evaluate the following dimensions: aggression, 
concentration, self-injury, substance misuse, school difficulties, physical illness, hallucinations, somatic 
disturbance, emotional issues, difficulties in peer relationships, independence, family relationships, and 
school attendance. It is composed of 15 items rated on a 5-point Likert scale, ranging from 0 (no problem) 
to 4 (severe problem). A higher score refers to more severe difficulties. In addition to the Total score, 
which we calculated by averaging Items 1 to 13 (Gowers et al., 1999), recent research on the factor 
structure of the HoNOSCA [22] suggested the use of two additional subscores: an Externalizing 
symptoms subscore (Ext; mean of Items 1, 2, 5, and 11) and an Emotional Problems subscore (Emo; 
mean of Items 3, 4, 6, 7, 8, 9, 10, 12, and 13). Complementary studies confirmed that the two additional 
subscores were sensitive measures of clinical improvement regardless of patients’ mental illnesses [23]. 
As Items 14 and 15 didn’t assess youths’ functioning, they have not been taken into account in our 
analyses.  
 
Overall level of functioning. The Global Assessment of Functioning Scale [GAF, 24] is one of 
the most widely used measures among psychiatric services to evaluate a global level of current 
functioning, including the severity of psychological symptoms [25]. It was developed as a single-item 
scale for clinical evaluation of the Axis V of the DSM-IV, with a score ranging from 0 (important 
functional impairment) to 100 (superior functioning). A score above 80 represents a good to superior 
functioning and lower scores represent a poorer functioning. It is inexpensive, easy to administer, and 
applies to all ages, making it an instrument of choice for comparing different populations. Moreover, this 
scale has an excellent interrater reliability and nomothetic validity [26,27].  
 
Procedure 
 The instruments were rated at admission and at discharge by the clinician who was in charge of 
the patient (and who knows him best). The clinician who rated the instruments could be a nurse, a social 
worker, or a psychiatrist. Each one of them was previously trained to use the instruments. 
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Statistical Analyses 
 A Multivariate Analysis of Variance (MANOVA) was used to examine the five types of treatment 
provided by the ACT teams as the independent variable (IV) and four outcomes as dependent variables 
(DVs): the total score of the HoNOSCA (Items 1 to 13), its Externalizing and Emotional problems 
subscores, and the GAF score. We then used linear mixed-effects models (LME) to model the effect of 
ACT on the four outcome measures. We followed these analyses by calculating a reliable change index 
[RCI; 11] for each outcome measure and by evaluating how many patients recovered, versus deteriorated, 
after ACT. The RCI is an index calculated using a statistical procedure to determine a degree of clinical 
significance that meets the standards of efficacy set by consumers and clinicians. According to Jacobson 
and colleagues [11], clinical significance is attained during the course of therapy when a patient moves 
from the dysfunctional towards the functional range. Accordingly, the RCI allows determining whether a 
given patient has crossed a clinical significance threshold (e.g., a meaningful reduction of symptoms), 
while simultaneously accounting for measurement error. It is calculated by subtracting the post-treatment 
score from the pre-treatment score and by dividing the result by the standard error of the differences. An 
RCI score ≥ 1.96 – that is a z-score level of significance of p < .05 – is then considered as a reliable 
change.  Finally, we used multivariate regressions to check whether treatment duration (IV) was a 
significant predictor of reliable change for each outcome (DVs). The data were analyzed using R software 
v3.1.2 [28]. 
 
Results 
 As the ACT teams provide five different types of interventions, we tested whether they had 
different effects on the outcomes. Because the assumptions of multivariate normality for a classical 
MANOVA were violated (Shapiro-Wilk tests were all significant, all ps < .001), we resorted to robust 
methods for calculating the MANOVA. Using Todorov and Filzmoser’s [29] method on the ranked data, 
the difference scores of the outcome variables were not affected by the type of treatment, λ(28) =  0.73, 
p = .48. We therefore conducted all our subsequent analyses without distinction between the types of 
treatment received by the participants. 
 Linear mixed-effects models (LME) on random intercepts were used with restricted maximum 
likelihood to model the evolution over time of each one of the four outcome measures (HoNOSCA-Total, 
HoNOSCA-Ext, HoNOSCA-Emo, and GAF). Time was considered as a fixed effect in our model, and 
because a given measure was supposed to be correlated for each patient across time, subjects were 
considered as random-effects. Table 2 shows that all three HoNOSCA scores significantly diminished 
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(i.e., reduction of problems) and that the GAF score increased (i.e., improvement of functioning) across 
time.  
 We then calculated a RCI [11] for each outcome measure. Figure 1 shows the amount of change 
for each patient after treatment. For each outcome, more patients improved than deteriorated. More 
specifically, the ratio of improvement on deterioration was the best for internalizing symptoms 
(HoNOSCA-Emo: 30/5 = 6), immediately followed by the overall level of functioning (GAF: 
23/4 = 5.75) and general difficulties related to mental illness (HoNOSCA-Tot: 30/6 = 5). The worse ratio 
was for externalizing symptoms (HoNOSCA-Ext: 20/11 = 1.82). On the whole, 47 (26.27%) patients 
improved, whereas only 14 (7.82%) deteriorated in at least one of the four outcome measures. 
 Finally, as treatment duration varied considerably between patients, we tested whether it was a 
significant predictor of RCI scores for each outcome. As illustrated by Figure 2, multivariate regressions 
showed that treatment duration does not affect clinical change in any of the four outcomes, all bs < 
| 0.001 |, all ps > .53. 
  
Discussion 
 Despite the proven efficacy of ACT on adult populations in the United States, research in Europe 
on both adult and adolescent populations has not come to definite conclusions [30]. The few European 
studies [1,31,32] concluding on a therapeutic efficacy of ACT only reported statistically significant 
changes. Although statistical significance is a good hint of the efficacy of ACT, it doesn’t necessary 
imply that the treatment results in clinical improvements felt by patients, nor that the considerable 
financial investment made in ACT leads to tangible results. Our study aimed at evaluating, in a 
naturalistic setting, both statistical and clinical efficacy of ACT among adolescent populations in 
Switzerland. 
 First, our results compared the outcomes of the five different types of interventions proposed by 
ACT teams in Switzerland (i.e., early intervention, transition case management, care for hardly accessible 
patients or in refusal of care, psychiatric assessment in the community and support in socio-educational 
institutions). Indeed, because of different health care systems across Europe, the implementation and 
structure of ACT teams doesn’t always correspond to the original ACT model. This point has often been 
raised as a possible explanation for the differences between European and American studies [33]. Because 
the types of interventions proposed by ACT teams in Switzerland is broader than the those of the original 
ACT model, it was necessary to test whether any, among their five types of interventions, was 
significantly more – or less – effective compared to the others. Our results showed no difference in 
outcomes between the five types of ACT interventions. Thus, even by adding interventions to the original 
model, their efficacy was similar as long as they were made by ACT teams. 
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 Second, we assessed the improvement in the overall level of functioning (i.e., GAF) and the 
reduction of difficulties related to mental illness (i.e., HoNOSCA) between admission and discharge from 
the ACT. Our results showed that both emotional and externalizing difficulties were reduced and that the 
psychological and social functioning of patients was improved after ACT. Unlike studies in the United 
Kingdom and in the Netherlands [34-36], our results are more in line with previous American and 
Australian studies on adolescent patients [5,7]. They also complement and extend the previous results 
obtained by other Swiss studies using the same type of ACT structure on both adult [37] and adolescent 
patients [1].  
 Third, after observing a statistically significant reduction of difficulties and an improvement in 
overall functioning, we confronted these statistical results to standards of efficacy set by patients and 
clinicians, by calculating a RCI [8]. To our knowledge, this is the first study on the efficacy of ACT for 
adolescents that assesses more than statistical significance and that extends its results to clinical 
significance. It thus constitutes an important and innovative point of our study, all the more so as the 
outcomes are positive. Indeed, among the patients followed by ACT teams, we observed encouraging 
recovery rates after treatment. More than a quarter of them (26.3%) passed from dysfunctional to 
functional levels on one of the outcome measures: 21.4% recovered from general difficulties related to 
their mental illness (HoNOSCA-Total), 21.4% recovered from emotional difficulties (HoNOSCA-Emo) 
and 14.1% recovered from externalizing problems (HoNOSCA-Ext). ACT also allowed 17.7% of patients 
to improve their overall level of functioning (GAF) until attaining levels closer to the functional 
population. The recovery rates of our sample may seem quite low compared to those of other 
psychotherapy studies focusing on improvement of very specific traits or symptoms and using the RCI for 
outcome measurement. For instance, it has been shown that the recovery ratio of callous-unemotional 
traits of delinquent adolescents following family therapy was between 12 and 48% [38]. In the same way, 
studies on both adult [39] and adolescent outpatients [40] highlighted that between 20 to 41% of them 
recovered from their symptoms after psychotherapy. However, as mentioned before, these studies were 
focusing on very specific outcomes and/or excluded patients with severe mental illness. In contrast to 
those studies, ACT treated hardly accessible patients, patients in refusal of classical treatment, and 
patients with severe mental illnesses. Studies including adolescent outpatients with more severe disorders 
(e.g., conduct disorders, autism spectrum disorders) report symptoms recovery rates among 15 to 26% of 
them [41], which is more in the range of what we observed. Moreover, in our study, very few patients 
clinically deteriorated following ACT, between 3.08% and 7.75%, which is still much lower than the 14 
to 24% of clinical deterioration that have been observed among outpatients in other studies [41]. In our 
sample, clinical improvement after ACT was between 5 to 6 times more frequent than deterioration. 
Taking into account that adolescent patients followed by ACT teams have often severe and chronic 
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psychiatric symptoms, these clinical recovery rates are rather promising. Our results also point out that 
ACT teams are more efficient in dealing with emotional symptoms, such as self-injury, addictive 
behaviors, hallucinations, or anxious and depressive symptoms, and in improving the overall social and 
psychological functioning levels, than they are regarding externalizing problems, such as disruptive and 
antisocial behaviors or scholastic skills (e.g., reading or counting). Conversely, the lower impact of ACT 
on externalizing symptoms may be explained by the fact that disruptive and antisocial behaviors generally 
need treatments that last much longer than 6 months, which corresponds to the mean duration of ACT. 
Moreover, according to ACT guidelines, teams are not supposed to try and treat these disorders, but to 
reorient patients to more containing structures, such as socio-educational institutions or child 
rehabilitation homes. 
  Despite these strengths, our study has some methodological limitations. For instance, our results 
consider ACT as a single, uniform treatment and don’t differentiate between the five types of 
interventions provided (which are not always mutually exclusive). Even if the effectiveness of these five 
interventions didn’t differ significantly with regards to our outcome measures, it would be interesting for 
future studies to identify more precisely which one is most effective, particularly in terms of clinical 
significance. Another limitation would be that we didn’t formally test inter-rater agreement between 
clinicians in this study. Because they were trained to use the HoNOSCA and the GAF, we inferred that 
their ratings would be accurate. Finally, as the time of post-treatment assessment was set at discharge 
from the program, one may expect that patients are discharged only when they have recovered. From this 
point of view, the efficacy of ACT teams in Switzerland may seem low as recovery rates much higher 
than 25% should be expected. However, the main objective of ACT is not to help patients recover from 
mental illness, but rather to help them to get proper treatment and to prevent deterioration. So, an 
improvement of 25% of patients’ functioning when only stabilization is expected may be considered as a 
pretty positive outcome. 
  
Conclusions 
 Contrary to other European countries, ACT teams in Switzerland proved some efficacy in dealing 
with severely ill patients or with patients in refusal of care. They also enable a substantial percentage of 
patients to recover from their difficulties, while also enabling those who don’t respond well to their 
treatment to be reoriented to appropriate care facilities. The specificities of their interventions – in 
particular the fact that they propose a broader range of interventions than what is proposed in the original 
ACT model – may be the factor explaining why their therapeutic success is higher than in other countries. 
Moreover, ACT teams in Switzerland seem to complement quite well other care structures, with which 
they pursue positive collaborations. This may create a synergetic effect that could be a possible 
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explanation of their successful results in Switzerland. Future studies should probably investigate the 
interrelations between different care structures in order to identify the factors that make ACT successful 
depending on different countries. 
 
Ethical Approval 
 This study is part of a larger project that aims to assess the quality and efficiency of ACT for 
different age spans (i.e., adults and adolescents), after its implementation in the state of Vaud 
(Switzerland). In Switzerland, this type of treatment has been designed with the main objective of 
managing patients who refuse regular psychiatric care and is used as last resort. Because ACT doesn’t 
necessitate an exclusive type of care, all patients followed by ACT teams were free to choose alternative 
treatment options. However, as soon as patients were able to invest another treatment option, the goal of 
reintegrating a health care system was achieved and the ACT teams withdrew from care. Each patient and 
his guardians were informed that routine clinical assessments were going to be made for scientific 
purposes and were asked for their informed consent. A refusal didn’t influence the proposed treatment. 
The study had the approval of Lausanne University Hospital Ethical Committee and has therefore been 
performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its 
later amendments. 
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Table 1 
Descriptive Characteristics of Participants (N = 179) 
Characteristic n % 
Gender (boys) 
Age 
102 56.98 
      8 - 11 4 2.41 
    12 - 15 59 35.54 
    16 - 19 103 62.05 
Social measure   
    Withdrawal of child custody 13 8.72 
    Help in schooling 12 8.05 
    Withdrawal of parental authority 12 8.05 
    Curatorship 7 4.70 
School drop outs 54 36.99 
Social care institution 56 36.61 
Attempted suicide  30 20.27 
Traumatic experience   
    Family discord 63 68.48 
    Parental separation 57 61.29 
    Mental disease in close family 39 46.43 
    Physical abuse 27 30.34 
    Migration 24 26.09 
    Family passing 20 21.73 
    Sexual abuse 17 18.89 
    Adoption 4 4.40 
    No traumatic experience 
Substance use 
33 18.43 
    Alcohol 67 45.89 
    Tobacco 55 37.93 
    Drugs 10 9.01 
    No substance use 46 25.70 
Diagnosis   
    Depression 62 34.64 
    Anxiety disorders 33 18.44 
    Conduct disorders 25 13.97 
    Personality disorder 19 10.61 
    Psychosis 18 10.06 
Note. Percentages are calculated on complete data for each item 
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Table 2 
Random Intercept Mixed Effects Models of Four Outcome Measures 
 Baseline Post-treatment        
Outcome M SD M SD Fixed effects Random effects Estimates SE df t SD 
HoNOSCA-Total 1.59 0.46 1.32 0.59 Intercept  1.858 0.067 247.800 27.655***  
     Time  -0.265 0.040 150.630 -6.676***  
      Patient     0.395 
      Residual     0.339 
HoNOSCA-Emo 1.61 0.43 1.31 0.57 Intercept  1.906 0.066 239.890 28.772***  
     Time  -0.295 0.040 151.670 -7.426***  
      Patient     0.365 
      Residual     0.340 
HoNOSCA-Ext 1.55 0.77 1.33 0.77 Intercept  1.740 0.098 254.180 17.83***  
     Time  -0.193 0.057 151.300 -3.36***  
      Patient     0.593 
      Residual     0.493 
GAF 49.46 12.44 55.14 14.63 Intercept  43.885 1.699 246.120 25.828***  
     Time  5.683 0.981 142.680 5.795***  
      Patient     10.735 
      Residual     8.125 
Note. Approximate degrees of freedom for t-test significance are based on Kenward-Roger method (1997). HoNOSCA = Health of the Nation Outcome Scales for Children and 
Adolescents; HoNOSCA-Emo = internalizing symptoms subscale; HoNOSCA-Ext = externalizing symptoms subscale; GAF = Global Assessment of Functioning Scale. 
*** p < .001 
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Figure 1. Evolution of each patient after treatment for four outcome variables. Shaded areas represent reliable change index intervals. Triangles 
represent patients with a clinical improvement after treatment; Squares represent patients with clinical deterioration; Points represent participants 
below the critical values of reliable change. Axes of the GAF plot are shifted to keep the recovered patients on top of the plot. 
ACT EFFICACY IN ADOLESCENTS              17 
 
Figure 2. Relationship between duration of ACT and four outcome variables. All regression lines are non-significant (all ps > .05). Shaded areas 
represent Wald confidence intervals. 
 
 
 
